Misinterpretation of time-to-first event curves can lead to inappropriate treatment
Eur Respir J
.
2019 Sep 5;54(3):1900634.
doi: 10.1183/13993003.00634-2019.
Print 2019 Sep.
Authors
Benjamin Hartley
1
,
Gerard J Criner
2
,
Mark T Dransfield
3
,
David M G Halpin
4
,
MeiLan K Han
5
,
C Elaine Jones
6
,
Sally Kilbride
7
,
Peter Lange
8
9
,
David A Lipson
10
11
,
David A Lomas
12
,
Neil Martin
13
14
,
Fernando J Martinez
15
,
Dave Singh
16
,
Robert A Wise
17
,
Sally Lettis
18
Affiliations
1
Statistics and Programming, Veramed Ltd, Twickenham, UK.
2
Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
3
Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA.
4
Dept of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK.
5
University of Michigan, Pulmonary and Critical Care, Ann Arbor, MI, USA.
6
GlaxoSmithKline, Research Triangle Park, NC, USA.
7
GlaxoSmithKline, Stockley Park West, Uxbridge, UK.
8
Dept of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
9
Medical Dept, Herlev and Gentofte Hospital, Herlev, Denmark.
10
GlaxoSmithKline, Collegeville, PA, USA.
11
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
12
UCL Respiratory, University College London, London, UK.
13
GlaxoSmithKline, Brentford, UK.
14
University of Leicester, Leicester, UK.
15
New York-Presbyterian Weill Cornell Medical Center, New York, NY, USA.
16
University of Manchester, Manchester, UK.
17
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
18
GlaxoSmithKline, Stockley Park West, Uxbridge, UK sally.x.lettis@gsk.com.
PMID:
31488584
DOI:
10.1183/13993003.00634-2019
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Precision Medicine*
Pulmonary Disease, Chronic Obstructive*
Grants and funding
MR/N024842/1/MRC_/Medical Research Council/United Kingdom